These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 403841)

  • 1. Gram-negative rod bacteremia: microbiologic, immunologic, and therapeutic considerations.
    Young LS; Martin WJ; Meyer RD; Weinstein RJ; Anderson ET
    Ann Intern Med; 1977 Apr; 86(4):456-71. PubMed ID: 403841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gram-hegative bacillemia.
    McHenry MC; Hawk WA; Straffon RA
    Urol Clin North Am; 1976 Jun; 3(2):333-51. PubMed ID: 822557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gram-negative pathogens in septicaemic infections.
    Young LS; Stevens P; Kaijser B
    Scand J Infect Dis Suppl; 1982; 31():78-94. PubMed ID: 6808659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-reactive antigens: their potential for immunization-induced immunity to Gram-negative bacteria.
    McCabe WR; Bruins SC; Craven DE; Johns M
    J Infect Dis; 1977 Aug; 136 Suppl():S161-6. PubMed ID: 330775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of phagocytic and bacterial cells in patients with bacteremia caused by gram-negative rods.
    van Dijk WC; Verbrugh HA; van der Tol ME; Peters R; Peterson PK; Quie PG; Verhoef J
    J Infect Dis; 1980 Apr; 141(4):441-9. PubMed ID: 6768810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential use of shared antigens for immunization against gram-negative bacillary infections.
    McCabe WR; DeMaria A; Johns M
    Prog Clin Biol Res; 1980; 47():107-17. PubMed ID: 6163155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gram-negative bacillary colonization and bacteremia in the compromised host.
    Young LS
    Infection; 1982; 10(5):319-23. PubMed ID: 6129196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients.
    Kreger BE; Craven DE; Carling PC; McCabe WR
    Am J Med; 1980 Mar; 68(3):332-43. PubMed ID: 6987870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial synergism in the therapy of gram-negative rod bacteremia.
    Anderson ET; Young LS; Hewitt WL
    Chemotherapy; 1978; 24(1):45-54. PubMed ID: 412648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-protective immunity to Gram-negative bacilli: studies with core glycolipid of Salmonella minnesota and antigens of Streptococcus pneumoniae.
    Young LS; Stevens P
    J Infect Dis; 1977 Aug; 136 Suppl():S174-80. PubMed ID: 19538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type-specific and cross-reactive antibodies in gram-negative bacteremia.
    McCabe WR; Kreger BE; Johns M
    N Engl J Med; 1972 Aug; 287(6):261-7. PubMed ID: 5038951
    [No Abstract]   [Full Text] [Related]  

  • 12. Epidemiology and clinical outcomes of multidrug-resistant, gram-negative bloodstream infections in a European tertiary pediatric hospital during a 12-month period.
    Folgori L; Livadiotti S; Carletti M; Bielicki J; Pontrelli G; Ciofi Degli Atti ML; Bertaina C; Lucignano B; Ranno S; Carretto E; Muraca M; Sharland M; Bernaschi P
    Pediatr Infect Dis J; 2014 Sep; 33(9):929-32. PubMed ID: 24642515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active immunization with a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine protects animals from experimental sepsis.
    Cross AS; Opal SM; Warren HS; Palardy JE; Glaser K; Parejo NA; Bhattacharjee AK
    J Infect Dis; 2001 Apr; 183(7):1079-86. PubMed ID: 11237833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticore endotoxin F(ab')2 equine immunoglobulin fragments protect against lethal effects of gram-negative bacterial sepsis.
    Dunn DL; Mach PA; Condie RM; Cerra FB
    Surgery; 1984 Aug; 96(2):440-6. PubMed ID: 6379963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiserum treatment of gram-negative bacteremia.
    Braude AI; Ziegler EJ; McCutchan JA
    Schweiz Med Wochenschr; 1978 Dec; 108(48):1872-6. PubMed ID: 362528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].
    Wang X; Zhao C; Li H; Chen H; Jin L; Wang Z; Liao K; Zeng J; Xu X; Jin Y; Su D; Liu W; Hu Z; Cao B; Chu Y; Zhang R; Luo Y; Hu B; Wang H
    Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1205-1217. PubMed ID: 30152206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of antibiotics, vasoactive drugs and steroids in Gram-negative bacteremia.
    Petersdorf RG; Beaty HN
    Ann N Y Acad Sci; 1967 Sep; 145(2):319-28. PubMed ID: 4327437
    [No Abstract]   [Full Text] [Related]  

  • 18. Gram-negative bacteremia of long duration. Clinical study of 29 patients.
    McHenry MC; Gavan TL; Hawk WA; Van Ommen RA; Ma CA
    Cleve Clin Q; 1973; 40(2):47-56. PubMed ID: 4577963
    [No Abstract]   [Full Text] [Related]  

  • 19. Low-Avidity Autoantibodies against Bactericidal/Permeability-Increasing Protein Occur in Gram-Negative and Gram-Positive Bacteremia.
    Theprungsirikul J; Thaden JT; Wierzbicki RM; Burns AS; Skopelja-Gardner S; Fowler VG; Winthrop KL; Martin IW; Rigby WFC
    Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32747603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility Profile of Ceftolozane/Tazobactam and Other Parenteral Antimicrobials Against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa From US Hospitals.
    Sutherland CA; Nicolau DP
    Clin Ther; 2015 Jul; 37(7):1564-71. PubMed ID: 26088525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.